This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • NGR015: Randomized double-blind phase III study of...
Clinical trial

NGR015: Randomized double-blind phase III study of NGR-hTNF plus best investigator�s choice (BIC) versus placebo plus BIC in previously treated patients with advanced malignant pleural mesothelioma (MPM)

Read time: 1 mins
Last updated:26th Oct 2010
To compare overall survival (OS) in patients randomized to NGR-hTNF plus BIC (Best Investigator Choice) versus patients randomized to placebo plus BIC
Category Value
Study start date 2010-10-26

View full details